Literature DB >> 27475490

One-dimensional and 2-dimensional tumor size measurement for prediction of lymph node metastasis in differentiated early gastric cancer with minute submucosal invasion.

Tae Jun Kim1, Hyuk Lee2, Yang Won Min1, Byung-Hoon Min1, Jun Haeng Lee1, Kyoung-Mee Kim3, Min-Ji Kim4, Kyunga Kim4, Poong-Lyul Rhee1, Jae J Kim1.   

Abstract

BACKGROUND AND AIMS: Differentiated minute submucosal cancers measuring ≤3 cm that exhibit no lymphovascular invasion are considered eligible for endoscopic resection; however, the ≤3-cm criterion remains debatable. The aim of this study was to verify the optimal tumor size cutoff for endoscopic resection eligibility, and to determine whether 2-dimensional tumor size measurement would be more accurate for this purpose.
METHODS: The clinicopathologic data for 574 patients undergoing curative surgery for differentiated minute submucosal cancer were reviewed retrospectively. A receiver operating curve analysis and bootstrapped samples were used to identify the optimal cutoff values for predicting lymph node (LN) metastasis.
RESULTS: Four hundred fourteen patients were eligible for the study. LN metastasis accompanied 2.5% of differentiated minute submucosal cancers that were ≤3 cm in size and lacked lymphovascular invasion. There was no lymph node metastasis in the tumors with 1-dimensional sizes ≤1.0 cm and 2-dimensional sizes ≤1.0 cm2. When 10,000 bootstrapped data were used, optimal cutoff values were 2.9 cm (LN metastasis: 2.1%) and 8.3 cm2 (LN metastasis: 2.5% incidence) for 1- and 2-dimensional tumor size, respectively. Although the area under the curve was 0.611 (P = .046) for 2-dimensional size, specificity and accuracy were greater for the dichotomized 2-dimensional measure than for the dichotomized 1-dimensional measure (P < .001, McNemar test). In addition, 2-dimensional tumor size was the only significant risk factor for LN metastasis (odds ratio, 1.09; 95% confidence interval, 1.01-1.20).
CONCLUSIONS: One- and 2-dimensional cutoff values of 2.9 cm and 8.3 cm2 might be suitable for patients at high risk of postoperative morbidity and mortality. Two-dimensional tumor size is an acceptable measurement method for estimating the risk of LN metastasis.
Copyright © 2017 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27475490     DOI: 10.1016/j.gie.2016.07.046

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  5 in total

1.  Clinical feasibility and oncologic safety of primary endoscopic submucosal dissection for clinical submucosal invasive early gastric cancer.

Authors:  Ji Eun Na; Hyuk Lee; Yang Won Min; Byung-Hoon Min; Jun Haeng Lee; Poong-Lyul Rhee; Kyoung-Mee Kim; Jae J Kim
Journal:  J Cancer Res Clin Oncol       Date:  2021-03-05       Impact factor: 4.553

2.  Postoperative outcomes of gastric carcinoma with lymphoid stroma.

Authors:  Kenichi Iwasaki; Takeshi Suda; Yuki Takano; Yuki Ohno; Erika Yamada; Naoto Okazaki; Kosuke Takahashi; Takafumi Watanabe; Yosuke Makuuchi; Yoshihiro Ota; Yoshiaki Osaka; Akiyoshi Seshimo; Kenji Katsumata; Akihiko Tsuchida
Journal:  World J Surg Oncol       Date:  2020-05-21       Impact factor: 2.754

3.  The longest diameter of tumor as a parameter of endoscopic resection in early gastric cancer: In comparison with tumor area.

Authors:  Yoo Jin Um; Hae Won Kim; Da Hyun Jung; Jie-Hyun Kim; Jae Jun Park; Young Hoon Youn; Hyojin Park; Jong Won Kim; Seung Ho Choi; Sung Hoon Noh
Journal:  PLoS One       Date:  2017-12-20       Impact factor: 3.240

4.  Measurement of tumor volume is not superior to diameter for prediction of lymph node metastasis in early gastric cancer with minute submucosal invasion.

Authors:  Jeung Hui Pyo; Sun-Ju Byeon; Hyuk Lee; Yang Won Min; Byung-Hoon Min; Jun Haeng Lee; Kyoung-Mee Kim; Hyeon Seon Ahn; Kyunga Kim; Yoon-Ho Choi; Jae J Kim
Journal:  Oncotarget       Date:  2017-12-04

5.  A prospective appraisal of preoperative body mass index in D2-resected patients with non-metastatic gastric carcinoma and Siewert type II/III adenocarcinoma of esophagogastric junction: results from a large-scale cohort.

Authors:  Lei Huang; Zhi-Jian Wei; Tuan-Jie Li; Yu-Ming Jiang; A-Man Xu
Journal:  Oncotarget       Date:  2017-07-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.